Neuroblastoma en el adulto. Informe de un caso

Zerrweck-López, Carlos; Quijano-Orvañanos, Fernando; Montañez-Ramírez, Horacio; Murillo-Zolezzi, Adrián; Toledo-Valdovinos, Sergio; Padilla-Longoria, Rafael
September 2009
Cirugia y Cirujanos;sep/oct2009, Vol. 77 Issue 5, p397
Academic Journal
Background: Neuroblastoma is a common malignancy in infancy but extremely rare in adults. These tumors, commonly found in the abdomen, originate in the sympathetic nervous system. Staging and management are standardized in children and adults, although their prognosis is very different, being more aggressive and with a poorer outcome in the adult. Clinical case: We present the case of a 31-year-old male with non-specific abdominal pain and constipation. After several studies, a stage III giant retroperitoneal neuroblastoma was diagnosed. We discuss here the evaluation, management and follow-up of the patient, as well as to present a literature review. Conclusions: Adult neuroblastoma is an unusual disease with an insidious presentation and is usually diagnosed in advanced stages. Unlike its behavior in young patients, in the adult it is more aggressive and with a poor prognosis.


Related Articles

  • Prox1 suppresses the proliferation of neuroblastoma cells via a dual action in p27-Kip1 and Cdc25A. Foskolou, I P; Stellas, D; Rozani, I; Lavigne, M D; Politis, P K // Oncogene;2/21/2013, Vol. 32 Issue 8, p947 

    Neuroblastoma is a pediatric tumor that originates from precursor cells of the sympathetic nervous system with less than 40% long-term survival in children diagnosed with high-risk disease. These clinical observations underscore the need for novel insights in the mechanisms of malignant...

  • Current status of molecular biology and treatment strategy for neuroblastoma. Mugishima, Hideo // International Journal of Clinical Oncology;Jun2012, Vol. 17 Issue 3, p189 

    No abstract available.

  • Effect of missense mutations on structure and interaction of anaplastic Lymphoma kinase (ALK) in neuroblastom. Kanwal, Hafsah; Khan, Mohammad Haroon; Rashi, Hamid // Pakistan Journal of Pharmaceutical Sciences;May2013, Vol. 26 Issue 3, p611 

    Neuroblastoma is a cancer of the sympathetic nervous system, accounting for upto 15% of childhood cancer mortality. It can occur in many areas but most of them begin in the abdomen in the adrenal gland and can spread to the bones and other areas,...

  • New Insights into the Genetics of Neuroblastoma. Sridhar, Srishma; Al-Moallem, Batool; Kamal, Hawra; Terrile, Marta; Stallings, Raymond // Molecular Diagnosis & Therapy;Apr2013, Vol. 17 Issue 2, p63 

    Neuroblastoma is a genetically and clinically heterogeneous tumor of childhood, arising from precursor cells of the sympathetic nervous system. It is still a challenging cancer for pediatric oncology, as some tumors will spontaneously regress, while others will become refractory to all forms of...

  • Incidencia y tendencia del neuroblastoma en niños derechohabientes del IMSS. Palma-Padilla, Virginia; Juárez-Ocaña, Servando; González-Miranda, Guadalupe; Siordia-Reyes, Alicia Georgina; Mejía-Aranguré, Juan Manuel; Carreón-Cruz, Rogelio; Fajardo-Gutiérrez, Arturo // Revista Medica del IMSS;mar/abr2010, Vol. 48 Issue 2, p151 

    Background: neuroblastoma (NB) is the principal tumor of the sympathetic nervous system in children. Objective: to describe the epidemiological and clinical characteristics of Mexican children with NB. Methods: a population-based, prolective study, with data obtained from the Childhood Cancer...

  • Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells. Schönherr, C; Ruuth, K; Kamaraj, S; Wang, C-L; Yang, H-L; Combaret, V; Djos, A; Martinsson, T; Christensen, J G; Palmer, R H; Hallberg, B // Oncogene;12/13/2012, Vol. 31 Issue 50, p5193 

    Neuroblastoma is a neural crest-derived embryonal tumour of the postganglionic sympathetic nervous system and a disease with several different chromosomal gains and losses, which include MYCN-amplified neuroblastoma on chromosome 2, deletions of parts of the chromosomes 1p and 11q, gain of parts...

  • The genetic landscape of high-risk neuroblastoma. Pugh, Trevor J; Morozova, Olena; Attiyeh, Edward F; Asgharzadeh, Shahab; Wei, Jun S; Auclair, Daniel; Carter, Scott L; Cibulskis, Kristian; Hanna, Megan; Kiezun, Adam; Kim, Jaegil; Lawrence, Michael S; Lichenstein, Lee; McKenna, Aaron; Pedamallu, Chandra Sekhar; Ramos, Alex H; Shefler, Erica; Sivachenko, Andrey; Sougnez, Carrie; Stewart, Chip // Nature Genetics;Mar2013, Vol. 45 Issue 3, p279 

    Neuroblastoma is a malignancy of the developing sympathetic nervous system that often presents with widespread metastatic disease, resulting in survival rates of less than 50%. To determine the spectrum of somatic mutation in high-risk neuroblastoma, we studied 240 affected individuals (cases)...

  • Podoplanin and LYVE-1 expression in lymphatic vessels of human neuroblastoma. Ribatti, Domenico; Nico, Beatrice; Cimpean, Anca; Raica, Marius // Journal of Neuro-Oncology;Nov2010, Vol. 100 Issue 1, p151 

    No abstract available.

  • Essential Role for p53 and Caspase-9 in DNA Damaging Drug-Induced Apoptosis in Neuroblastoma IMR32 Cells. Li, Tai; Cui, Zhao-Bo; Ke, Xiao-Xue; Tan, Juan; Li, Fang-Fang; Li, Ting; Wang, Xiang-Wei; Cui, Hong-Juan // DNA & Cell Biology;Dec2011, Vol. 30 Issue 12, p1045 

    Neuroblastoma is a solid tumor of the sympathetic nervous system accounting for up to 10% of pediatric cancers and 15% of cancer-related deaths. It is a useful system for investigation of stress signal-mediated apoptosis as a tumor suppression mechanism. In this study, we present evidence that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics